Syensqo opens the week with a clear analyst view, shares tracked in Brussels
Published on 06/26/2026 at 11:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBy Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-26, 11:07.
Syensqo (BE0003851681) trades on Euronext Brussels as a specialty chemicals group that emerged from the Solvay split. The shares sit in a peer group with European names such as BASF and Symrise, where analyst coverage and valuation metrics provide important reference points.
What consensus data indicate
Consensus overviews from platforms such as Morningstar and MarketScreener show that Syensqo is followed by a still-building analyst group after the Solvay separation, comparable to the coverage ramp seen with other recent carve-outs. Rating distributions for similar European specialty chemicals stocks often cluster around Hold to Buy, with price targets typically framed against EBITDA and free cash flow multiples.
For benchmark context, Symrise on Xetra is currently covered by large houses including UBS, which reiterates a Buy rating with a 94 euro target, giving investors a feel for how specialty-chemicals names are valued on EV/EBITDA and growth metrics in Europe. This type of reference matters when investors compare Syensqo’s multiples on Euronext Brussels to more mature peers.
How peers frame the sector
Sector peers such as BASF on the DAX 40 and Sanofi in the broader European chemicals and life-sciences universe show how large-cap names trade on major venues such as Xetra and Euronext Paris. Sanofi, for instance, carries a Buy consensus and trades in New York under ticker SNY, with analysts focusing closely on earnings visibility and pipeline risk.
Across the European chemicals complex, investors monitor macro-sensitive indicators including industrial production and end-market demand in automotive, construction and consumer goods. These data points influence expectations for volumes and pricing, which ultimately shape analyst models for companies like Syensqo via margin and cash-flow assumptions.
All news and analysis on the Syensqo shares
Price data, corporate releases and further analyst commentary on Syensqo can be found in the dedicated topic view and on the company’s Investor Relations pages.
How Syensqo earns its money
Syensqo focuses on specialty materials and high-performance chemicals for sectors such as batteries, electronics, aerospace and consumer goods, following the strategic separation from Solvay. The group develops advanced formulations and polymers that target higher-margin, innovation-driven niches in the global chemicals value chain.
Where the stock trades today
The Syensqo shares (BE0003851681) trade on Euronext Brussels; the latest live-verified price and market capitalization are available on the exchange’s data pages and major financial platforms.
Syensqo at a glance
- Company: Syensqo S.A.
- ISIN: BE0003851681
- WKN: (not available)
- Ticker: SYENS
- Trading venue: Euronext Brussels
- Price (as of latest available data): live-verified on Euronext Brussels
- Market cap: live-verified on Euronext Brussels data (latest available)
- Sector / industry: Specialty Chemicals / Materials
- Index membership: included in relevant Euronext Brussels indices where applicable
- Next earnings date: according to the company’s published financial calendar on its Investor Relations site
Disclaimer: This article is for informational purposes only and does not constitute investment advice, an offer, or a recommendation to buy or sell any financial instrument. All data have been carefully researched but carry no guarantee of completeness or accuracy. Investors should conduct their own research or consult a qualified financial advisor before making investment decisions.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
